1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA WDR76 CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA C1orf162 CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA ZEB1 CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA ETS1 CTRPv2 pan-cancer AAC -0.16 7e-06
mRNA BAG2 CTRPv2 pan-cancer AAC -0.16 7e-06
mRNA CFD CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA PARVG CTRPv2 pan-cancer AAC 0.18 8e-06
mRNA ACOT11 CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA SPECC1L-ADORA2A CTRPv2 pan-cancer AAC -0.17 8e-06
mRNA KLF3 CTRPv2 pan-cancer AAC 0.18 8e-06
Download CSV